Literature DB >> 30638421

The role of infections in multiple sclerosis.

Mariano Marrodan1, Lucas Alessandro1, Mauricio F Farez2, Jorge Correale3.   

Abstract

Several lines of evidence suggest that multiple sclerosis (MS), like other autoimmune diseases, may be triggered by microbial infections. Pathogens associated with development or exacerbation of MS include bacteria, such as Chlamydia pneumoniae, Staphylococcus aureus-produced enterotoxins that function as superantigens, and viruses of the Herpesviridae (Epstein-Barr virus and human herpes virus 6) and human endogenous retrovirus families. However, to date, no single pathogen has been accepted as causal agent. In addition, common upper respiratory, gastrointestinal, and urogenital tract infections have also been associated with MS exacerbations. Although evidence of an infectious etiology as cause of MS in humans remains inconclusive, microbial agents may modulate the neuroimmunological system of genetically susceptible individuals. Decoding the epidemiological contribution of different microorganisms to MS, along with their pathogenic mechanisms, may help develop new treatment strategies and prevent relapses.

Entities:  

Keywords:  Exacerbations; infections; infectious agents; multiple sclerosis; relapses

Mesh:

Year:  2019        PMID: 30638421     DOI: 10.1177/1352458518823940

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  30 in total

1.  Measurement of mucociliary clearance in the patients with multiple sclerosis.

Authors:  Ender Sahin; Mehmet Hamamcı; Yunus Kantekin
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-09       Impact factor: 2.503

2.  COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.

Authors:  Afagh Garjani; Rodden M Middleton; Rachael Hunter; Katherine A Tuite-Dalton; Alasdair Coles; Ruth Dobson; Martin Duddy; Stella Hughes; Owen R Pearson; David Rog; Emma C Tallantyre; Roshan das Nair; Richard Nicholas; Nikos Evangelou
Journal:  Mult Scler Relat Disord       Date:  2021-05-05       Impact factor: 4.808

3.  The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre.

Authors:  Matteo Lucchini; Paola Del Giacomo; Valeria De Arcangelis; Viviana Nociti; Assunta Bianco; Chiara De Fino; Giorgia Presicce; Alessandra Cicia; Vincenzo Carlomagno; Massimiliano Mirabella
Journal:  J Pers Med       Date:  2022-04-07

4.  Nimodipine Exerts Beneficial Effects on the Rat Oligodendrocyte Cell Line OLN-93.

Authors:  Felix Boltz; Michael Enders; Andreas Feigenspan; Philipp Kirchner; Arif Ekici; Stefanie Kuerten
Journal:  Brain Sci       Date:  2022-04-04

5.  HERQ-9 Is a New Multiplex PCR for Differentiation and Quantification of All Nine Human Herpesviruses.

Authors:  Hannamari Välimaa; Maria F Perdomo; Lari Pyöriä; Maija Jokinen; Mari Toppinen; Henri Salminen; Tytti Vuorinen; Veijo Hukkanen; Constanze Schmotz; Endrit Elbasani; Päivi M Ojala; Klaus Hedman
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

Review 6.  COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.

Authors:  Shaghayegh Sadeghmousavi; Nima Rezaei
Journal:  SN Compr Clin Med       Date:  2020-09-03

Review 7.  The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System.

Authors:  Raquel Bello-Morales; Sabina Andreu; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 8.  Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection.

Authors:  Júlia Leão Batista Simões; Julia Beatrice de Araújo; Margarete Dulce Bagatini
Journal:  Mol Neurobiol       Date:  2021-07-11       Impact factor: 5.590

Review 9.  Chronic Inflammatory Diseases at Secondary Sites Ensuing Urogenital or Pulmonary Chlamydia Infections.

Authors:  Yi Ying Cheok; Chalystha Yie Qin Lee; Heng Choon Cheong; Chung Yeng Looi; Won Fen Wong
Journal:  Microorganisms       Date:  2020-01-17

Review 10.  Multiple sclerosis and drug discovery: A work of translation.

Authors:  Bert A 't Hart; Antonio Luchicchi; Geert J Schenk; Joep Killestein; Jeroen J G Geurts
Journal:  EBioMedicine       Date:  2021-05-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.